MHRA authorises Onswik (insulin efsitora alfa) for adults with type 2 diabetes

Medicines and Healthcare products Regulatory Agency Version 1 original current

Imported from official source

The new treatment option is administered once weekly, potentially reducing the number of injections from up to 365 a year to 52 for some adults with type 2 diabetes.

This version

Version: 1 of 1
Recorded: October 13, 2026 14:01
Change: Initial
Content hash: 4046211b9c626204171f41608f729881
All versions: Revision history